| Clinical experience with transcutaneous supraorbital nerve stimulation in patients with refractory migraine or with migraine and intolerance to topiramate: a prospective … M Vikelis, EV Dermitzakis, KC Spingos, GG Vasiliadis, GS Vlachos, ... BMC neurology 17, 1-7, 2017 | 55 | 2017 |
| Patients’ preferences for headache acute and preventive treatment DD Mitsikostas, I Belesioti, C Arvaniti, E Mitropoulou, C Deligianni, ... The Journal of Headache and Pain 18, 1-8, 2017 | 54 | 2017 |
| Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment M Vikelis, AA Argyriou, EV Dermitzakis, KC Spingos, N Makris, ... The journal of headache and pain 19, 1-6, 2018 | 37 | 2018 |
| Onabotulinumtoxin-A treatment in Greek patients with chronic migraine M Vikelis, AA Argyriou, EV Dermitzakis, KC Spingos, DD Mitsikostas The Journal of Headache and Pain 17, 1-5, 2016 | 37 | 2016 |
| The impact of paclitaxel and carboplatin chemotherapy on the autonomous nervous system of patients with ovarian cancer EV Dermitzakis, VK Kimiskidis, G Lazaridis, Z Alexopoulou, ... BMC neurology 16, 1-6, 2016 | 31 | 2016 |
| Headache patients in the emergency department of a Greek tertiary care hospital EV Dermitzakis, G Georgiadis, J Rudolf, D Nikiforidou, P Kyriakidis, ... The journal of headache and pain 11, 123-128, 2010 | 30 | 2010 |
| OnabotulinumtoxinA add-on to monoclonal anti-CGRP antibodies in treatment-refractory chronic migraine AA Argyriou, EV Dermitzakis, G Xiromerisiou, M Vikelis Toxins 14 (12), 847, 2022 | 21 | 2022 |
| Open label prospective experience of supplementation with a fixed combination of magnesium, vitamin B2, feverfew, andrographis paniculata and coenzyme Q10 for episodic migraine … M Vikelis, EV Dermitzakis, GS Vlachos, P Soldatos, KC Spingos, ... Journal of Clinical Medicine 10 (1), 67, 2020 | 15 | 2020 |
| Long‐term adherence, safety, and efficacy of repeated onabotulinumtoxinA over five years in chronic migraine prophylaxis AA Argyriou, EV Dermitzakis, GS Vlachos, M Vikelis Acta Neurologica Scandinavica 145 (6), 676-683, 2022 | 14 | 2022 |
| Analysis of HCRTR2, GNB3, and ADH4 Gene Polymorphisms in a Southeastern European Caucasian Cluster Headache Population M Papasavva, MS Katsarou, M Vikelis, E Mitropoulou, EV Dermitzakis, ... Journal of Molecular Neuroscience 70, 467-474, 2020 | 12 | 2020 |
| VDR Gene Polymorphisms and Cluster Headache Susceptibility: Case–Control Study in a Southeastern European Caucasian Population M Papasavva, M Vikelis, V Siokas, MS Katsarou, E Dermitzakis, A Raptis, ... Journal of Molecular Neuroscience, 1-11, 2022 | 11 | 2022 |
| The impact of oxaliplatin‐based chemotherapy for colorectal cancer on the autonomous nervous system EV Dermitzakis, VK Kimiskidis, A Eleftheraki, G Lazaridis, A Konstantis, ... European Journal of Neurology 21 (12), 1471-1477, 2014 | 11 | 2014 |
| Efficacy and safety of fremanezumab for migraine prophylaxis in patients with at least three previous preventive failures: prospective, multicenter, real‐world data from a … AA Argyriou, EV Dermitzakis, G Xiromerisiou, D Rallis, P Soldatos, ... European Journal of Neurology 30 (5), 1435-1442, 2023 | 10 | 2023 |
| Workload of the emergency room neurologists and the neurological inpatient department in a Greek tertiary care hospital J Rudolf, EV Dermitzakis, E Kyriazopoulou, D Nikiforidou, I Gravas, ... Clinical neurology and neurosurgery 112 (4), 332-335, 2010 | 10 | 2010 |
| Rhino‐cerebral zygomycosis resistant to antimycotic treatment: a case report TA Vyzantiadis, A Kioumi, E Papadakis, M Braimi, E Dermitzakis, ... Mycoses 52 (1), 87-90, 2009 | 10 | 2009 |
| Variability in oxidative stress-related genes (SOD2, CAT, GPX1, GSTP1, NOS3, NFE2L2, and UCP2) and susceptibility to migraine clinical phenotypes and features M Papasavva, M Vikelis, V Siokas, MS Katsarou, EV Dermitzakis, A Raptis, ... Frontiers in Neurology 13, 1054333, 2023 | 9 | 2023 |
| Predictors of response to fremanezumab in migraine patients with at least three previous preventive failures: post hoc analysis of a prospective, multicenter, real-world Greek … AA Argyriou, EV Dermitzakis, G Xiromerisiou, D Rallis, P Soldatos, ... Journal of Clinical Medicine 12 (9), 3218, 2023 | 7 | 2023 |
| Effects of fremanezumab on psychiatric comorbidities in difficult-to-treat patients with chronic migraine: post hoc analysis of a prospective, multicenter, real-world Greek … M Vikelis, EV Dermitzakis, G Xiromerisiou, D Rallis, P Soldatos, ... Journal of Clinical Medicine 12 (13), 4526, 2023 | 6 | 2023 |
| Results of a Web-Based Survey on 2105 Greek Migraine Patients—Second Part: Efficacy of Acute and Prophylactic Migraine Treatments and Corresponding Patients’ Reported Satisfaction EV Dermitzakis, A Kouroudi, AA Argyriou, KC Spingos, K Bilias, M Vikelis Medicina 59 (1), 31, 2022 | 5 | 2022 |
| Results of a Web-based survey of 2105 Greek migraine patients in 2020: demographics, clinical characteristics, burden and the effects of the COVID-19 pandemic on the course of … EV Dermitzakis, A Kouroudi, AA Argyriou, KC Spingos, K Bilias, M Vikelis BMC neurology 22 (1), 440, 2022 | 5 | 2022 |
